HR 166Session 2026rs
Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
House
Read for the first time and referred to the House Committee on Rules
-
House
Pending Committee Action in House of Origin (Rules)